Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Ge

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Erratum: Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Molecular Therapy. Methods & Clinical Development|November 29, 2023
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
Nature Medicine|May 12, 2026
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trialJohn F DiPersio, Guenther Koehne, Nirali N Shah, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Erratum: Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Molecular Therapy. Methods & Clinical Development|November 29, 2023
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
Nature Medicine|May 12, 2026
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trialJohn F DiPersio, Guenther Koehne, Nirali N Shah, et al.
Pageof 2